Prestige Consumer Healthcare Inc. (PBH)

Market Cap	3.54B
Revenue (ttm)	1.13B
Net Income (ttm)	-80.67M
Shares Out	49.69M
EPS (ttm)	-1.60
PE Ratio	n/a
Forward PE	15.44
Dividend	n/a
Ex-Dividend Date	n/a

Volume	166,699
Open	69.95
Previous Close	69.80
Day's Range	69.95 - 71.81
52-Week Range	52.90 - 75.31
Beta	0.53
Analysts	Hold
Price Target	60.00 (-15.75%)
Earnings Date	May 6, 2024

About PBH

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wa...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Feb 10, 2005
• Employees: 560
• Stock Exchange: NYSE
• Ticker Symbol: PBH

Analyst Forecast

According to one analyst, the rating for PBH stock is "Hold" and the 12-month stock price forecast is $60.0.

Price Target

$60.0

(-15.75% downside)

Analyst Consensus: Hold